Metabolic Syndrome
📧 Sign up to get email alerts when something new happens for Metabolic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity [NA]
The clinical trial evaluating the effects of vitamin K2 on osteocalcin, leptin, cytokines, and cardiovascular risk in young adults with over…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition [NA]
This clinical trial update reports the completion of evaluating AKK Formula on intestinal microbiota regulation and body composition in part…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Optimal Timing of Physical Activity in Cancer Treatment [NA]
The clinical trial on the optimal timing of physical activity during cancer treatment has completed. The sponsor was University Medical Cent…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention
A completed clinical trial update evaluating maternal and offspring obesity and metabolic risk after a prepregnancy weight-loss intervention…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: A Study on the Intervention of Metabolic Syndrome Patients With Exercise Prescription Based on Ventilatory Threshold Using Cardiopulmonary Exercise Test [NA]
A completed clinical trial evaluating an exercise prescription for metabolic syndrome patients based on ventilatory threshold assessed by ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities [Phase 4]
Phase 4 trial evaluating safety and effectiveness of saroglitazar 4 mg in patients with NAFLD and comorbidities.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities [Phase 4]
Phase IV trial comparing MICARDIS 80 mg to amlodipine 10 mg assessing biological PPAR gamma activities in hypertension and metabolic syndrom…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Nuts and Oil Pilot Study [NA]
Pilot clinical trial evaluating nuts and oil in metabolic syndrome has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics [Phase 4]
Phase 4 clinical trial comparing topiramate and metformin on cardio-metabolic outcomes in schizophrenia patients treated with atypical antip…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals [Phase 1, Phase 2]
A clinical trial update on oral 6-bromotryptophan assessing safety, pharmacokinetics, and efficacy in metabolic syndrome and diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome [Phase 4]
A Phase 4 clinical trial evaluating blood pressure control with telmisartan or losartan in patients with essential hypertension and metaboli…
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating 3-V Bioscience-2640 to reduce de novo lipogenesis in adult…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults [NA]
Completed clinical trial evaluating a short-term, structured weight loss plan in overweight and obese adults with metabolic syndrome; result…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome [Phase 2, Phase 3]
Phase 2/3 trial updating on free fatty acid reduction and its impact on vascular function in metabolic syndrome; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Improving Metabolic Health in Patients With Diastolic Dysfunction [NA]
A completed clinical trial from UT Southwestern investigating metabolic health improvements in patients with diastolic dysfunction, obesity,…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2, Phase 3]
Phase 2/3 trial investigating Amla for metabolic syndrome, focusing on insulin sensitivity and insulin secretion.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing infusion of umbilical cord-derived versus bone marrow-derived mesenchymal stem cells for cytokine suppr…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: 2-5 Intermittent Caloric Restriction in HIV [NA]
Clinical trial of intermittent caloric restriction in people with HIV and metabolic syndrome was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Dapagliflozin Effect in Cognitive Impairment in Stroke Trial [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating dapagliflozin for cognitive impairment in stroke patients is in early or unknown status.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans [Phase 4]
Phase 4 trial update evaluating the effects of SGLT-2 inhibition on sympathetic nervous system activity in humans with metabolic syndrome an…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Liraglutide for HIV-associated Neurocognitive Disorder [Phase 4]
Phase 4 trial of liraglutide for HIV-associated neurocognitive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2]
Phase 2 clinical trial evaluating the effect of ellagic acid on metabolic syndrome components, insulin sensitivity, and insulin secretion.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) [Phase 2]
Phase 2 trial investigating chloroquine for metabolic syndrome conditions has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Vestibular Stimulation to Trigger Adipose Loss Clinical Trial
A terminated clinical trial investigating vestibular stimulation for adipose loss in obesity and related conditions; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients [Phase 4]
Phase 4 trial updating a comparison between berberine and metformin for metabolic syndrome in schizophrenia patients.